Overview

Efficacy of Pentoxifylline on Cerebrovascular Function in Patients With Cerebral Small Vessel Disease(PERFORM)

Status:
Not yet recruiting

Trial end date:
2024-03-31

Target enrollment:

Participant gender:

Summary

This is a randomized, double-blinded, placebo-controlled, multi-center trial. Cerebral small vessel disease (CSVD) patients will be diagnosed according to STRIVE standards and randomized into the Pentoxifylline sustained-release tablet group and placebo group. The purpose of this trial is to assess the efficacy of Pentoxifylline sustained- release tablets on CSVD.

Phase:

Phase 4

Details

Lead Sponsor:

Beijing Tiantan Hospital

Collaborator:

CSPC Ouyi Pharmaceutical Co., Ltd.

Treatments:

Pentoxifylline